HOFBF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Nov 25 closing price
TPIA
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
Ad is loading...

HOFBF vs TPIA

Header iconHOFBF vs TPIA Comparison
Open Charts HOFBF vs TPIABanner chart's image
Hofseth Biocare ASA
Price$0.10
Change-$0.00 (-0.00%)
Volume$21.2K
CapitalizationN/A
Mycotopia Therapies
Price$0.01
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
HOFBF vs TPIA Comparison Chart
Loading...
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOFBF vs. TPIA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOFBF is a Hold and TPIA is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (HOFBF: $0.10 vs. TPIA: $0.01)
Brand notoriety: HOFBF and TPIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOFBF: 171% vs. TPIA: 29%
Market capitalization -- HOFBF: $65.18M vs. TPIA: $84.47K
HOFBF [@Biotechnology] is valued at $65.18M. TPIA’s [@Biotechnology] market capitalization is $84.47K. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOFBF’s FA Score shows that 0 FA rating(s) are green whileTPIA’s FA Score has 1 green FA rating(s).

  • HOFBF’s FA Score: 0 green, 5 red.
  • TPIA’s FA Score: 1 green, 4 red.
According to our system of comparison, both HOFBF and TPIA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOFBF’s TA Score shows that 2 TA indicator(s) are bullish while TPIA’s TA Score has 4 bullish TA indicator(s).

  • HOFBF’s TA Score: 2 bullish, 2 bearish.
  • TPIA’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, TPIA is a better buy in the short-term than HOFBF.

Price Growth

HOFBF (@Biotechnology) experienced а 0.00% price change this week, while TPIA (@Biotechnology) price change was -25.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.34%. For the same industry, the average monthly price growth was -2.42%, and the average quarterly price growth was +0.75%.

Industries' Descriptions

@Biotechnology (-4.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOFBF($65.2M) has a higher market cap than TPIA($84.5K). TPIA YTD gains are higher at: -6.250 vs. HOFBF (-54.545). TPIA has higher annual earnings (EBITDA): -765.51K vs. HOFBF (-83.4M). HOFBF has more cash in the bank: 23.4M vs. TPIA (202K). TPIA has less debt than HOFBF: TPIA (1.27M) vs HOFBF (185M). HOFBF has higher revenues than TPIA: HOFBF (240M) vs TPIA (0).
HOFBFTPIAHOFBF / TPIA
Capitalization65.2M84.5K77,160%
EBITDA-83.4M-765.51K10,894%
Gain YTD-54.545-6.250873%
P/E RatioN/AN/A-
Revenue240M0-
Total Cash23.4M202K11,584%
Total Debt185M1.27M14,625%
FUNDAMENTALS RATINGS
HOFBF vs TPIA: Fundamental Ratings
HOFBF
TPIA
OUTLOOK RATING
1..100
1816
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9293
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOFBF's Valuation (48) in the null industry is somewhat better than the same rating for TPIA (95). This means that HOFBF’s stock grew somewhat faster than TPIA’s over the last 12 months.

HOFBF's Profit vs Risk Rating (100) in the null industry is in the same range as TPIA (100). This means that HOFBF’s stock grew similarly to TPIA’s over the last 12 months.

HOFBF's SMR Rating (98) in the null industry is in the same range as TPIA (100). This means that HOFBF’s stock grew similarly to TPIA’s over the last 12 months.

HOFBF's Price Growth Rating (92) in the null industry is in the same range as TPIA (93). This means that HOFBF’s stock grew similarly to TPIA’s over the last 12 months.

TPIA's P/E Growth Rating (1) in the null industry is significantly better than the same rating for HOFBF (100). This means that TPIA’s stock grew significantly faster than HOFBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOFBFTPIA
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
40%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
14%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
23%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
15%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
26%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
26%
N/A
View a ticker or compare two or three
Ad is loading...
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MENIX9.61-0.16
-1.64%
Madison Covered Call & Equity Income I
MIGYX57.29-1.72
-2.91%
Invesco Main Street Y
FSMVX32.80-1.16
-3.42%
Fidelity Mid Cap Value
RYGRX83.34-3.41
-3.93%
Rydex S&P 500 Pure Growth C
NBRIX13.82-0.58
-4.03%
Neuberger Berman Real Estate I

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been loosely correlated with BIVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOFBF jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
BIVI - HOFBF
44%
Loosely correlated
-14.86%
MPSYF - HOFBF
41%
Loosely correlated
N/A
ETXPF - HOFBF
38%
Loosely correlated
N/A
PHGE - HOFBF
35%
Loosely correlated
-6.60%
INNMF - HOFBF
23%
Poorly correlated
N/A
More

TPIA and

Correlation & Price change

A.I.dvisor tells us that TPIA and PALI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TPIA and PALI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPIA
1D Price
Change %
TPIA100%
+6.38%
PALI - TPIA
25%
Poorly correlated
-7.89%
VANI - TPIA
25%
Poorly correlated
-6.92%
CDXC - TPIA
23%
Poorly correlated
-5.00%
SBHMY - TPIA
22%
Poorly correlated
N/A
HOFBF - TPIA
21%
Poorly correlated
N/A
More